167 related articles for article (PubMed ID: 17848741)
1. Long-term complications of platinum-based chemotherapy in testicular cancer survivors.
Oh JH; Baum DD; Pham S; Cox M; Nguyen ST; Ensor J; Chen I
Med Oncol; 2007; 24(2):175-81. PubMed ID: 17848741
[TBL] [Abstract][Full Text] [Related]
2. Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
Boer H; Proost JH; Nuver J; Bunskoek S; Gietema JQ; Geubels BM; Altena R; Zwart N; Oosting SF; Vonk JM; Lefrandt JD; Uges DR; Meijer C; de Vries EG; Gietema JA
Ann Oncol; 2015 Nov; 26(11):2305-10. PubMed ID: 26347114
[TBL] [Abstract][Full Text] [Related]
3. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy.
Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; de Kam ML; de Roos A; Lamb HJ; Osanto S
Acta Oncol; 2014 Mar; 53(3):351-60. PubMed ID: 23957624
[TBL] [Abstract][Full Text] [Related]
4. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Gerl A; Schierl R
Acta Oncol; 2000; 39(4):519-22. PubMed ID: 11041115
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.
Trendowski MR; El-Charif O; Ratain MJ; Monahan P; Mu Z; Wheeler HE; Dinh PC; Feldman DR; Ardeshir-Rouhani-Fard S; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Mushiroda T; Kubo M; Hannigan R; Strathmann F; Einhorn LH; Fossa SD; Travis LB; Dolan ME
Clin Cancer Res; 2019 Oct; 25(19):5913-5924. PubMed ID: 31296530
[TBL] [Abstract][Full Text] [Related]
7. Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
Hjelle LV; Gundersen PO; Oldenburg J; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Bremnes RM; Haugnes HS
Anticancer Res; 2015 Mar; 35(3):1619-25. PubMed ID: 25750319
[TBL] [Abstract][Full Text] [Related]
8. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
10. The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer.
Fenton DW; Verma S; Venner P; Sawhney R; Mackey JR
J Urol; 2002 Nov; 168(5):1971-4. PubMed ID: 12394687
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
12. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
14. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
16. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin.
Gelevert T; Messerschmidt J; Meinardi MT; Alt F; Gietema JA; Franke JP; Sleijfer DT; Uges DR
Ther Drug Monit; 2001 Apr; 23(2):169-73. PubMed ID: 11294519
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for chronic kidney disease after chemotherapy for testicular cancer.
Inai H; Kawai K; Ikeda A; Ando S; Kimura T; Oikawa T; Onozawa M; Miyazaki J; Uchida K; Nishiyama H
Int J Urol; 2013 Jul; 20(7):716-22. PubMed ID: 23186076
[TBL] [Abstract][Full Text] [Related]
18. The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.
Khanal N; Ahmed SS; Kalra M; Miller TJ; Brames MJ; Stump TE; Monahan P; Hanna NH; Einhorn LH
Support Care Cancer; 2020 Jul; 28(7):3165-3170. PubMed ID: 31707501
[TBL] [Abstract][Full Text] [Related]
19. [Long-term side effects of chemotherapy for testicular cancer].
Kawai K
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1300-5. PubMed ID: 12146015
[TBL] [Abstract][Full Text] [Related]
20. Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study.
Blaes AH; Mulrooney DA; Vogel RI; Solovey A; Hebbel R; Peterson BA; Neglia JP; Biewen C; Konety SH; Duprez DA
Vasc Health Risk Manag; 2018; 14():205-211. PubMed ID: 30237722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
